Metastatic colon cancer, version 3.2013 Journal Article
| Authors: | Benson, A. B. 3rd; Bekaii-Saab, T.; Chan, E.; Chen, Y. J.; Choti, M. A.; Cooper, H. S.; Engstrom, P. F.; Enzinger, P. C.; Fakih, M. G.; Fenton, M. J.; Fuchs, C. S.; Grem, J. L.; Hunt, S.; Kamel, A.; Leong, L. A.; Lin, E.; May, K. S.; Mulcahy, M. F.; Murphy, K.; Rohren, E.; Ryan, D. P.; Saltz, L.; Sharma, S.; Shibata, D.; Skibber, J. M.; Small, W. Jr; Sofocleous, C. T.; Venook, A. P.; Willett, C. G.; Gregory, K. M.; Freedman-Cass, D. A. |
| Article Title: | Metastatic colon cancer, version 3.2013 |
| Abstract: | The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, peri-operative treatment, patient surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Colon Cancer Panel meets annually to review comments from reviewers within their institutions and to reevaluate and update their recommendations. In addition, the panel has interim conferences as new data necessitate. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel's discussions surrounding metastatic colorectal cancer for the 2013 update of the guidelines. Importantly, changes were made to the continuum of care for patients with advanced or metastatic disease, including new drugs and an additional line of therapy. Copyright © 2013 JNCCN-Journal of the National Comprehensive Cancer Network. |
| Keywords: | cancer chemotherapy; cancer survival; cancer surgery; overall survival; clinical feature; histopathology; bevacizumab; fluorouracil; placebo; advanced cancer; diarrhea; disseminated cancer; drug safety; drug withdrawal; hypertension; unspecified side effect; capecitabine; cancer patient; cancer staging; neurotoxicity; cancer diagnosis; colorectal cancer; cytoreductive surgery; low drug dose; metastasis; progression free survival; infection; liver toxicity; colonic neoplasms; practice guideline; cetuximab; cancer mortality; irinotecan; panitumumab; drug hypersensitivity; rash; patient care; liver metastasis; lung metastasis; drug mechanism; add on therapy; folinic acid; colon cancer; practice guidelines as topic; aflibercept; neoplasm metastasis; medical oncology; cancer fatigue; colon resection; stent; perioperative period; cancer epidemiology; carcinomatous peritonitis; oncogene k ras; mitomycin; oxaliplatin; general practitioner; peritoneum metastasis; fluoropyrimidine; cerebrovascular accident; desquamation; venous thromboembolism; colostomy; elective surgery; randomized controlled trial (topic); meta analysis (topic); phase 3 clinical trial (topic); metastatic colorectal cancer; systematic review (topic); regorafenib |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 11 |
| Issue: | 2 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2013-02-01 |
| Start Page: | 141 |
| End Page: | 152 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 23411381 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 April 2013" - "Source: Scopus" |
